Table II.
Angiographic and procedural characteristics
| Parameter | Unmatched cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
| BP-SES (n = 886) | DP-EES (n = 1054) | P-value | BP-SES (n = 886) | DP-EES (n = 1054) | P-value | |
| Multi-vessel CAD (%) | 68.1 | 69.4 | 0.54 | 67.6 | 68.2 | 0.82 |
| LM CAD (%) | 4.1 | 7.4 | < 0.01 | 4.8 | 4.8 | 0.99 |
| Target vessel (%): | ||||||
| LM | 1.9 | 6.5 | < 0.01 | 2.4 | 2.2 | 0.86 |
| LAD | 28.3 | 44.1 | < 0.01 | 33.0 | 33.3 | 0.91 |
| Cx | 31.4 | 27.4 | 0.05 | 30.1 | 29.9 | 0.68 |
| RCA | 42.9 | 32.4 | < 0.01 | 38.9 | 38.1 | 0.74 |
| Bypass | 4.2 | 3.1 | 0.22 | 3.7 | 4.0 | 0.78 |
| Single vessel PCI (%) | 79.8 | 74.9 | 0.40 | 78.9 | 80.7 | 0.41 |
| Bifurcation PCI (%) | 10.5 | 18.50 | < 0.01 | 11.8 | 11.3 | 0.80 |
| Stents used per patient, mean ± SD | 1.53 ±0.88 | 1.52 ±0.83 | 0.64 | 1.52 ±0.86 | 1.50 ±0.81 | 0.60 |
| Total length of stents, mean ± SD | 29.10 ±18.63 | 32.31 ±19.79 | < 0.01 | 30.18 ±19.25 | 30.00 ±17.92 | 0.86 |
| Maximal implantation pressure, mean ± SD | 14.58 ±2.23 | 14.67 ±2.58 | 0.52 | 14.62 ±2.21 | 14.53 ±2.58 | 0.57 |
| Direct stent implantation (%) | 33.4 | 29.9 | 0.1 | 31.1 | 31.2 | 0.72 |
| Post-dilatation (%) | 23.9 | 25.0 | 0.57 | 22.8 | 24.4 | 0.49 |
| Thrombectomy (%) | 9.9 | 9.3 | 0.63 | 9.7 | 9.5 | 0.93 |
| Procedural glycoprotein IIb/IIIa inhibitor (%) | 8.3 | 11.0 | 0.05 | 9.0 | 9.9 | 0.56 |
CAD – coronary artery disease, LM – left main, LAD – left anterior descending, Cx – circumflex, RCA – right coronary artery, PCI – percutaneous coronary intervention.